SCHEMBL18753660

SCHEMBL18753660

COc1cc(C(=O)N2CCN(CC3CCCCC3)CC2)ccc1N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR4 Q13639 11/20 0.50
▸ ACHE P22303 9/20 0.50
▸ HSD11B1 P28845 1/20 0.49
▸ SIGMAR1 Q99720 1/20 0.48
▸ NAMPT P43490 1/20 0.48
▸ CHRM4 P08173 1/20 0.48
▸ CHRM5 P08912 1/20 0.48
▸ ADRA2C P18825 1/20 0.48
▸ CHRM3 P20309 1/20 0.48
▸ HTR1D P28221 1/20 0.48
▸ ADRA1B P35368 1/20 0.48
▸ HTR2B P41595 1/20 0.48
▸ HTR3A P46098 1/20 0.48
▸ KMT2A Q03164 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ CNR1 P21554 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13880931 0.94 HTR4 (0.52) HTR4HSD11B1CHRM4CHRM5ADRA2C
SCHEMBL21230145 0.85 PDE4A (0.47) HTR4ACHENAMPTKMT2AALDH1A1
SCHEMBL18753954 0.83 ALDH1A1 (0.50) HTR4HSD11B1CHRM4CHRM5ADRA2C
SCHEMBL15880929 0.83 ALDH1A1 (0.59) HSD11B1KMT2AALDH1A1POLBCYP2C19
SCHEMBL15649918 0.82 ALDH1A1 (0.57) HSD11B1KMT2AALDH1A1POLBCYP2C19
SCHEMBL13575486 0.82 HPGD (0.63) HSD11B1KMT2AALDH1A1POLBCYP2C19
SCHEMBL18753556 0.82 ALDH1A1 (0.56) HTR4HSD11B1CHRM4CHRM5ADRA2C
SCHEMBL20750393 0.81 KDM4E (0.40) HTR4HSD11B1KMT2AALDH1A1
SCHEMBL1782181 0.80 HPGD (0.64) HSD11B1KMT2AALDH1A1POLBCYP2C19
SCHEMBL15651739 0.80 HPGD (0.60) HSD11B1KMT2AALDH1A1POLBCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3241554-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2020-01-29 — — EP disclosed
EP-2448582-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2017-04-19 — — EP disclosed
Send feedback